City of Tampa v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:18-op-46282 |
| Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
| Cause | No cause code entered |
| Case Filed: | Nov 30, 2018 |
| Case in other court: | Florida Middle, 8:18-cv-02792 |
| Last checked: Friday Nov 08, 2019 7:02 PM EST |
|
Defendant
Insys Therapeutics Inc.
|
Represented By
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Walgreens Boots Alliance Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Mallinckrodt LLC
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
H.D. Smith LLC
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
CVS Health Corporation
|
Represented By
|
|
Defendant
Anda Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Allergan Finance LLC
|
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Plaintiff
City of Tampa
|
Represented By
|
| Docket last updated: 04/08/2019 8:13 PM EDT |
| Tuesday, November 13, 2018 | ||
| 1 | 1
NOTICE OF REMOVAL from 13th Judicial Circuit in and for Hillsborough County, Florida, case number 18-CA-009614 filed in State Court on 10/02/2018. Filing fee $ 400, receipt number 113A-14816436 filed by McKesson Corporation.(Silverglate, Spencer) [Transferred from flmd on 11/30/2018.]
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Exhibit C,
|
||
|
Att: 4
Exhibit D,
|
||
|
Att: 5
Exhibit E,
|
||
|
Att: 6
Exhibit F
|
||
| 2 | 2 NEW CASE ASSIGNED to Judge Steven D. Merryday and Magistrate Judge Christopher P. Tuite. New case number: 8:18-cv-2792-T-23CPT. (NAS) [Transferred from flmd on 11/30/2018.] | |
| Wednesday, November 14, 2018 | ||
| 3 | 3
NOTICE of designation under Local Rule 3.05 - Track 2. (GSO) [Transferred from flmd on 11/30/2018.]
|
|
| 4 | 4
ORDER re 3 --notice of designation of track. See document for details. Signed by Judge Steven D. Merryday on 11/14/2018. (GSO) [Transferred from flmd on 11/30/2018.]
|
|
| Tuesday, November 20, 2018 | ||
| 5 | 5
Unopposed MOTION for Extension of Time to File Response/Reply as to1 Notice of Removal Amended Complaint (jointly with Cardinal Health, Inc., AmerisourceBergen Corporation, CVS Health Corporation and H.D. Smith, LLC) by McKesson Corporation. (Silverglate, Spencer) Motions referred to Magistrate Judge Christopher P. Tuite. [Transferred from flmd on 11/30/2018.]
|
|
| 6 | 6
CERTIFICATE of interested persons and corporate disclosure statement by McKesson Corporation. (Silverglate, Spencer) [Transferred from flmd on 11/30/2018.]
|
|
| Wednesday, November 21, 2018 | ||
| 7 | 7 ENDORSED ORDER granting 5 Defendants' Joint Unopposed Motion for Extension of Time to Respond to Amended Complaint. Defendants' answers or responses shall be due the later of (a) 30 days after the final ruling of the Judicial Panel on Multidistrict Litigation regarding transfer of this of this case to the Northern District of Ohio to become a part of MDL-2804: In re: National Prescription Opiate Litigation, or (b) 30 days after a decision by this Court on whether this action should be remanded to state court. Signed by Magistrate Judge Christopher P. Tuite on 11/21/2018. (AHA) [Transferred from flmd on 11/30/2018.] | |
| Monday, November 26, 2018 | ||
| 8 | 8
Joint MOTION for Extension of Time to File Response/Reply to Amended Complaint and Joint Notice of Adoption by Purdue Pharma L.P.. (Kissane, Daniel) Motions referred to Magistrate Judge Christopher P. Tuite. [Transferred from flmd on 11/30/2018.]
|
|
| Tuesday, November 27, 2018 | ||
| 9 | 9 ENDORSED ORDER granting 8 Defendants Purdue, Mallinckrodt, EHSI, EPI, TEVA, INSYS, Johnson & Johnson, and Janssen's Joint Motion for Extension of Time to Respond to Amended Complaint. Defendants' answers or responses shall be due the later of (a) 30 days after the final ruling of the Judicial Panel on Multidistrict Litigation regarding transfer of this of this case to the Northern District of Ohio to become a part of MDL-2804: In re: National Prescription Opiate Litigation, or (b) 30 days after a decision by this Court on whether this action should be remanded to state court. Signed by Magistrate Judge Christopher P. Tuite on 11/27/2018. (AHA) [Transferred from flmd on 11/30/2018.] | |
| Wednesday, November 28, 2018 | ||
| 10 | 10
NOTICE of pendency of related cases re4 Order per Local Rule 1.04(d) by AmerisourceBergen Corporation. Related case(s): y (Pratico, Steven) [Transferred from flmd on 11/30/2018.]
|
|
| 11 | 11
CERTIFICATE of interested persons and corporate disclosure statement by AmerisourceBergen Corporation identifying Other Affiliate Amerisourcebergen Drug Corporation, Other Affiliate Amerisourcebergen Corp., Other Affiliate AmerisourceBergen Services Corporation for AmerisourceBergen Corporation.. (Pratico, Steven) [Transferred from flmd on 11/30/2018.]
|
|
| 12 | 12
NOTICE of pendency of related cases re4 Order per Local Rule 1.04(d) by H.D. Smith, LLC. Related case(s): yes (Gerber, Daniel) [Transferred from flmd on 11/30/2018.]
|
|
| 13 | 13
CERTIFICATE of interested persons and corporate disclosure statement by H.D. Smith, LLC. (Gerber, Daniel) [Transferred from flmd on 11/30/2018.]
|
|
| 14 | 14
NOTICE of pendency of related cases re4 Order per Local Rule 1.04(d) by Purdue Pharma L.P.. Related case(s): yes (Kissane, Daniel) [Transferred from flmd on 11/30/2018.]
|
|
| 15 | 15
CERTIFICATE of interested persons and corporate disclosure statement by Purdue Pharma L.P.. (Kissane, Daniel) [Transferred from flmd on 11/30/2018.]
|
|
| 16 | 16
NOTICE of pendency of related cases re4 Order per Local Rule 1.04(d) by Mallinckrodt LLC. Related case(s): Yes (Hearn, Robert) [Transferred from flmd on 11/30/2018.]
|
|
| 17 | 17
CERTIFICATE of interested persons and corporate disclosure statement re4 Order by Mallinckrodt LLC. (Hearn, Robert) [Transferred from flmd on 11/30/2018.]
|
|
| 18 | 18
NOTICE of pendency of related cases re4 Order per Local Rule 1.04(d) by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuical Industries Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. Related case(s): yess (Ercole, Brian) [Transferred from flmd on 11/30/2018.]
|
|
| 19 | 19
CERTIFICATE of interested persons and corporate disclosure statement re4 Order by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuical Industries Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc... (Ercole, Brian) [Transferred from flmd on 11/30/2018.]
|
|
| 20 | 20
NOTICE of pendency of related cases per Local Rule 1.04(d) by Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. Related case(s): Yes (Gulde, Virginia) [Transferred from flmd on 11/30/2018.]
|
|
| 21 | 21
CORPORATE Disclosure Statement by Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. (Gulde, Virginia) [Transferred from flmd on 11/30/2018.]
|
|
| 22 | 22
NOTICE of Appearance by Amy E. Furness on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals, Inc. (Furness, Amy) [Transferred from flmd on 11/30/2018.]
|
|
| 23 | 23
NOTICE of pendency of related cases re4 Order per Local Rule 1.04(d) by Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. Related case(s): yes (Furness, Amy) [Transferred from flmd on 11/30/2018.]
|
|
| 24 | 24
CERTIFICATE of interested persons and corporate disclosure statement re4 Order by Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Furness, Amy) [Transferred from flmd on 11/30/2018.]
|
|
| Thursday, November 29, 2018 | ||
| 25 | 25
MULTIDISTRICT LITIGATION panel order transferring case to: Northern District of Ohio re: MDL case number: 2804. (AG) [Transferred from flmd on 11/30/2018.]
|
|
| Friday, November 30, 2018 | ||
| 26 | 26
CASE TRANSFERRED IN from District of Florida Middle. Case number 8:18-cv-02792. Original file, certified copy of transfer order and docket sheet received.
|
|